Le Lézard
Classified in: Health, Science and technology
Subject: PLW

New Patent Issued for UVision360, INC. LUMINELLE® DTx System


RALEIGH, N.C., Feb. 24, 2021 /PRNewswire/ -- UVision360, Inc., an innovative FemTech company, announces today that the United States Patent and Trademark Office has issued a system method patent, No.10926059, for the Company's LUMINELLE® DTx System (LUMINELLE).

The new patent allows UVision360 to protect the method of assembly and manufacturing of the LUMINELLE system and sheaths with a rotatable function and includes a variety of manufacturing techniques and technologies that would be required to manufacture a device with the LUMINELLE's unique features.

"This patent, when paired with the LUMINELLE system utility patent, provides a broad spectrum of utility and method claims protecting the sale and manufacturing of our technology and specific features," says UVision360 CEO Allison London Brown. "This gives us the ability to confidently broaden the development of our technology to further help fill unmet medical needs."

About UVision360
UVision360, Inc. is dedicated to advancing access to care for women by transitioning procedures from the operating room to their physician's office. The company has created the LUMINELLE DTx System, a simplified, compact, and modular endoscopic system employing the latest in high-tech optics and interchangeable accessories to meet the needs of physicians and patients. More information about the LUMINELLE® DTx Hysteroscopy System can be found by contacting [email protected] or visiting www.luminelle360.com

SOURCE UVision360, Inc


These press releases may also interest you

at 01:20
Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its financial results from the first quarter 2024. Almirall delivered strong sales growth in the first quarter of 2024 which continues to be driven by the...

at 01:00
AnX Robotica, the leader in advanced gastrointestinal visualization technologies, is happy to announce a recent publication validating the clinical benefits of using ProScan, the first FDA cleared AI Assisted Reading Tool for Small Bowel Video...

at 00:00
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago from May 31 to June 4, 2024. As the largest and most academically prestigious international oncology conference in the world, the ASCO Annual Meeting gathers...

12 mai 2024
In a significant stride for urological health, Rigicon Inc. proudly announces groundbreaking enhancements to its ContiReflex® artificial urinary sphincter and Testi10 testicular prosthesis. These state-of-the-art developments, recently showcased at...

12 mai 2024
SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced first preclinical data of its novel human papillomavirus (HPV)-specific T cell...

12 mai 2024
Zai Lab Limited today announced that the National Medical Products Administration (NMPA) in China has approved the New Drug Application (NDA) for AUGTYROtm (repotrectinib) for the treatment of adult patients with locally advanced or metastatic...



News published on and distributed by: